flutamide

The drug is used for the treatment of locally advanced or metastatic prostate cancer. It may be used either as monotherapy or in combination with other therapeutic methods to reduce tumor volume and enhance disease control.

Form: tablets

ATC: L02BB01

Manufacturer: Orion Corporation (manufacturer carrying out all production stages except batch release; alternative manufacturer carrying out primary, secondary packaging and batch release)

The drug is used for the treatment of prostate cancer (either as monotherapy or in combination with other agents), as well as for the treatment of women with hyperandrogenic conditions accompanied by menstrual cycle disturbances, infertility, and hirsutism.

Form: tablets

ATC: L02BB01

Manufacturer: Farmak JSC

The drug is prescribed to women for the treatment of functional hyperandrogenism accompanied by menstrual cycle disturbances, infertility, hirsutism (excessive hair growth), and polycystic ovary syndrome.

Form: tablets

ATC: L02BB01

Manufacturer: Farmak JSC